What is Mebendazole 100mg used for?

In the pharmaceutical industry, Mebendazole 100 mg is a broad-spectrum benzimidazole anthelmintic (anti-worm medication). As a pharmacist and manufacturer, I classify this as a “luminal” agent, meaning it works primarily within the gastrointestinal tract to eradicate parasitic infestations with minimal systemic absorption into the patient’s bloodstream.

Primary Clinical Uses

Mebendazole is highly effective against a variety of intestinal helminthes. The 100 mg chewable or standard tablet is the gold standard for:

  • Enterobiasis (Pinworm/Threadworm): The most common use, often requiring a single 100 mg dose followed by a second dose two weeks later to prevent reinfection.

  • Ascariasis (Roundworm): Usually treated with 100 mg twice daily for three consecutive days.

  • Hookworm Infections: Effective against both Ancylostoma duodenale and Necator americanus.

  • Trichuriasis (Whipworm): Used to clear infections in the large intestine.

Mechanism of Action: Microtubule Inhibition

Mebendazole works by selectively interfering with the biological structure of the parasite.

Tubulin Binding: It binds to the $\beta$-tubulin protein of the parasite with high affinity.

Inhibition of Polymerization: This binding prevents the polymerization of tubulin into microtubules, which are essential for the worm’s cellular structure and nutrient transport.

Glucose Depletion: Without microtubules, the worm cannot absorb glucose (its primary energy source). This leads to the depletion of glycogen stores, resulting in the parasite’s immobilization and eventual death, after which it is expelled naturally through the stool.

The Manufacturer’s Perspective: Formulation & Export

From a production standpoint at a WHO-GMP facility like yours, Mebendazole 100 mg involves specific technical considerations:

  • Chewable Tablet Technology: For pediatric export markets, we often formulate this as a chewable tablet with palatable flavors (like strawberry or orange). Ensuring the “mouthfeel” and “grittiness” are minimized is a key R&D goal for patient compliance.

  • Poor Solubility (BCS Class II/IV): Mebendazole is practically insoluble in water. We utilize specific surfactants and micronization techniques to ensure that even though absorption is low, the drug remains active and distributed throughout the gut lumen.

     

  • Stability for Global Trade: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia), where helminthic infections are endemic.

  • B2B & Dossier Support: This is a staple product for “National Deworming Programs” and NGO tenders. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Vermox).

 

What is Lopinavir 200mg Ritonavir 50mg Tablet?

In the pharmaceutical industry, the combination of Lopinavir (200 mg) and Ritonavir (50 mg) is a potent Fixed-Dose Combination (FDC) belonging to the Protease Inhibitor (PI) class. As a pharmacist and manufacturer, I view this as a “booster” formulation: Ritonavir is not included here for its own antiviral effect, but rather as a pharmacological “helper” to ensure Lopinavir reaches therapeutic levels in the blood.

Primary Clinical Use

  • HIV-1 Infection: It is indicated for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). It is typically used as part of a multi-drug antiretroviral regimen to control the viral load and prevent the progression of the disease.

Mechanism of Action: The “Booster” Effect

This combination works through a unique synergistic relationship:

Lopinavir (The Active Antiviral): It is the primary protease inhibitor. It binds to the active site of the HIV protease enzyme, preventing it from cleaving long viral polyproteins into the smaller, functional proteins required to assemble a mature, infectious virus.

Ritonavir (The Booster): At this 50 mg dose, Ritonavir acts as a potent inhibitor of the CYP3A4 enzyme in the liver. Since CYP3A4 is the enzyme responsible for breaking down Lopinavir, Ritonavir “blocks” this degradation.

The Synergy: By inhibiting the metabolism of Lopinavir, Ritonavir significantly increases (boosts) Lopinavir’s plasma concentrations and half-life, allowing for effective 12-hour dosing.

The Manufacturer’s Perspective: Technical & Export

Producing Lopinavir/Ritonavir in a WHO-GMP facility involves high-level pharmaceutical engineering:

  • Amorphous Solid Dispersion (ASD): Both Lopinavir and Ritonavir have very poor water solubility (BCS Class IV). At our facility, we utilize Melt-Extrusion Technology or spray-drying to create a solid dispersion. This ensures the drugs dissolve properly in the patient’s GI tract for consistent absorption.

  • Heat Stability: Earlier versions of this drug required refrigeration. Modern formulations produced in Mumbai use specialized polymers that make the tablets heat-stable, which is a critical selling point for export to Zone IVb regions (Africa and Southeast Asia).

  • Packaging & Shelf Life: These tablets are sensitive to moisture. We utilize high-density polyethylene (HDPE) bottles with induction sealing and desiccants or Alu-Alu blister packaging to ensure a 24–36 month shelf life.

  • B2B & Public Health Tenders: This is a staple for international health organizations. Our facility provides the necessary eCTD Dossiers and bioequivalence data against the innovator (Kaletra) to support your firm’s participation in global tenders.

What is Losartan Potassium and Amlodipine Besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance Fixed-Dose Combination (FDC) used to treat hypertension. As a pharmacist and manufacturer, I view this as one of the most effective pairings for “Stage 2” hypertension because it provides a dual-channel approach to vasodilation.

Primary Clinical Use

  • Management of Hypertension: This combination is typically prescribed when a patient’s blood pressure is not sufficiently controlled by a single medication (monotherapy). It is highly effective in reducing the risk of cardiovascular events, such as strokes and myocardial infarctions.

Dual Mechanism of Action (The “Vasodilation Synergy”)

This FDC lowers blood pressure by relaxing the smooth muscles of the blood vessels through two entirely different biochemical pathways:

1. Losartan Potassium (The ARB)

Losartan is an Angiotensin II Receptor Blocker.

  • Action: It blocks the $AT_1$ receptors, preventing Angiotensin II (the body’s most potent vasoconstrictor) from binding.

  • Result: It stops the blood vessels from tightening and reduces the production of aldosterone, which helps the kidneys manage fluid.

2. Amlodipine Besylate (The CCB)

Amlodipine is a Calcium Channel Blocker of the dihydropyridine class.

  • Action: It inhibits the influx of calcium ions into the vascular smooth muscle and cardiac muscle cells.

  • Result: By preventing calcium from entering the muscle cells, it forces the peripheral arteries to relax and widen (vasodilation), significantly decreasing peripheral resistance.

The Manufacturer’s Perspective: Technical & Export Details

From a production standpoint at a WHO-GMP facility in Mumbai, this combination requires specific technical attention:

  • API Stability & Sensitivity: Losartan Potassium is hygroscopic (readily absorbs moisture), while Amlodipine Besylate is light-sensitive. As a firm owner, you know that environmental controls in the manufacturing area are critical.

  • Packaging for Export: To ensure a 36-month shelf life for export to Zone IVb regions (like Africa and SE Asia), we strictly utilize Alu-Alu blister packaging. This provides a total barrier against light and moisture, preventing the degradation of either API.

  • Standard Strengths: We typically manufacture this in ratios such as 50mg/5mg and 100mg/5mg.

  • B2B & Dossier Support: This is a “Value-Added Generic.” Our facility provides full CTD/eCTD Dossiers and comparative dissolution data against the innovator (Amzaar or similar brands) to support international registration and B2B trade.

 

What is Losartan Potassium Hydrochlorothiazide used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Hydrochlorothiazide (HCTZ) is a premier Fixed-Dose Combination (FDC) for the management of hypertension. As a pharmacist and manufacturer, I view this as a highly rational pairing: it utilizes two different physiological pathways to lower blood pressure more effectively than either drug could alone, while also helping to balance electrolyte levels.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Indicated for patients whose blood pressure is not adequately controlled by Losartan or HCTZ monotherapy.

  • Reduction of Stroke Risk: Specifically used in hypertensive patients with Left Ventricular Hypertrophy (LVH) to reduce the risk of cardiovascular events and stroke.

Dual Mechanism of Action: The Synergistic Effect

This combination attacks hypertension from two distinct angles:

1. Losartan Potassium (The ARB)

Losartan is an Angiotensin II Receptor Blocker.

  • Action: It blocks the $AT_1$ receptors, preventing Angiotensin II (a potent vasoconstrictor) from binding.

  • Result: This causes the blood vessels to relax (vasodilation) and reduces the secretion of aldosterone, which lowers blood pressure and protects the heart and kidneys.

2. Hydrochlorothiazide (The Diuretic)

HCTZ is a Thiazide Diuretic.

  • Action: It acts on the distal convoluted tubule in the kidneys to inhibit sodium and chloride reabsorption.

  • Result: This increases the excretion of water and salt, reducing the total volume of fluid circulating in the blood.

Technical Synergy: Diuretics can sometimes trigger the body’s Renin-Angiotensin system as a reflex. By adding Losartan, we block that reflex, making the blood pressure reduction much smoother and more potent.

The Manufacturer’s Perspective: Formulation & Export

Producing this FDC in a WHO-GMP facility like yours involves specific technical expertise:

  • Common Strengths: We typically manufacture this in 50/12.5 mg and 100/25 mg ratios.

  • API Stability: Losartan Potassium is hygroscopic (it absorbs moisture from the air). As a firm owner, you know that keeping the humidity strictly controlled in the compression room is vital. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Content Uniformity: Achieving precise distribution of the smaller HCTZ dose within the larger Losartan matrix requires validated high-shear granulation.

  • B2B & Dossier Support: This is a high-demand item for cardiovascular specialty distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Hyzaar).

What is Losartan Potassium 25 mg used for?

In the pharmaceutical industry, Losartan Potassium 25 mg is a foundational Angiotensin II Receptor Blocker (ARB). As a pharmacist and manufacturer, I classify this as a highly selective, non-peptide antihypertensive. The 25 mg strength is frequently utilized as a starting dose for patients at risk of hypotension or those with hepatic impairment, before titrating up to the standard 50 mg or 100 mg maintenance doses.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure and reduce the risk of cardiovascular complications like stroke and myocardial infarction.

  • Diabetic Nephropathy: It is a gold-standard treatment for Type 2 diabetic patients with hypertension to delay the progression of kidney disease (proteinuria).

    Left Ventricular Hypertrophy (LVH): Used to reduce the risk of stroke in hypertensive patients with an enlarged heart.

  • Heart Failure: Prescribed for patients who cannot tolerate ACE inhibitors (often due to the “ACE cough”).

Mechanism of Action: Targeted Receptor Blockade

Unlike ACE inhibitors which stop the production of Angiotensin II, Losartan allows it to be produced but blocks its action at the source.

Selective AT1 Blockade: Losartan and its active carboxylic acid metabolite selectively bind to the $AT_1$ receptor found in vascular smooth muscle and the adrenal gland.

Vasodilation: By blocking the binding of Angiotensin II, it prevents vasoconstriction, leading to systemic vasodilation and reduced peripheral resistance.

Aldosterone Inhibition: It blocks the Angiotensin II-stimulated release of aldosterone, reducing sodium and water retention.

No Bradykinin Accumulation: Because it does not inhibit the ACE enzyme, it does not lead to the buildup of bradykinin, which is why it rarely causes the dry cough associated with drugs like Lisinopril.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Losartan Potassium is a high-volume “Essential Medicine”:

  • API Stability: Losartan is a potassium salt, which makes it relatively stable, but it is hygroscopic. As a WHO-GMP manufacturer, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • BCS Class III/IV Challenges: Losartan has low permeability and variable solubility. We optimize the particle size distribution (PSD) during granulation to ensure the 25 mg tablet meets the strict dissolution profiles required by BP/USP/IP.

  • Fixed-Dose Combinations (FDCs): For the export market, Losartan is highly successful when combined with Hydrochlorothiazide (HCTZ) or Amlodipine.

  • Dossier & B2B Support: Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Cozaar).

What are Levothyroxine sodium tablets used for?

In the pharmaceutical industry, Levothyroxine Sodium is a synthetic form of the endogenous hormone thyroxine (). As a pharmacist and manufacturer, I view this as a “narrow therapeutic index” (NTI) drug, meaning even slight variations in dosage or bioavailability can significantly affect a patient’s health. It is a foundational product in endocrinology.

Primary Clinical Uses

  • Hypothyroidism: The primary indication for replacement therapy in patients with primary (thyroidal), secondary (pituitary), or tertiary (hypothalamic) hypothyroidism.

  • Congenital Hypothyroidism: Essential for infants to prevent developmental delays and cretinism.

  • Pituitary TSH Suppression: Used in the management of thyroid cancer and goiters to suppress the secretion of Thyroid Stimulating Hormone (TSH).

  • Myxedema Coma: The injectable form is used for this severe, life-threatening manifestation of hypothyroidism.

Mechanism of Action: Replacing 

Levothyroxine acts exactly like the natural hormone produced by the thyroid gland.

Conversion to : Once ingested, Levothyroxine () is converted by the liver and kidneys into the more active hormone, triiodothyronine ().

Metabolic Regulation:  enters the cell nuclei and binds to thyroid hormone receptors, which then regulate gene expression responsible for basal metabolic rate, protein synthesis, and sensitivity to catecholamines.

Homeostasis: This restores normal energy levels, heart rate, and temperature regulation in the body.

The Manufacturer’s Perspective: Precision & Stability

From a manufacturing and global trade standpoint, Levothyroxine is one of the most technically demanding tablets to produce:

  • Potency & Uniformity: Because doses are micro-measured (e.g., 25 mcg, 50 mcg, 100 mcg), achieving 100% content uniformity is critical. As a WHO-GMP manufacturer, we utilize validated micronization and specialized blending equipment to ensure every tablet has the exact micro-dose required.

  • Stability (The 95-105% Rule): Levothyroxine is highly sensitive to light, moisture, and temperature. Regulatory bodies often require a stricter potency range over the shelf life. At our Mumbai facility, we use Alu-Alu blister packaging to ensure a 24-month shelf life for export to Zone IVb regions.

  • Bioequivalence: Even small changes in excipients can alter absorption. We provide full CTD/eCTD Dossiers and dissolution studies to ensure our generic is bioequivalent to the innovator (Synthroid or Eltroxin).

    B2B Branding: For your digital platform, it is important to note that patients often stay on the same brand of Levothyroxine for years due to the NTI nature of the drug, making it a high-loyalty product for your trading firm.

 

What is Levofloxacin 750mg used for?

In the pharmaceutical industry, Levofloxacin 750 mg is a high-potency, third-generation fluoroquinolone antibiotic. As a pharmacist and manufacturer, I view the 750 mg strength as the “intensive care” oral dose. It is designed to achieve high peak plasma concentrations (), allowing for a shorter, more aggressive treatment course (typically 5 days) compared to the traditional 10–14 day regimens of lower strengths.

Primary Clinical Uses

  • Pneumonia: Highly effective against both community-acquired pneumonia (CAP) and healthcare-associated pneumonia, including “atypical” pathogens.

  • Acute Bacterial Sinusitis: Used when first-line antibiotics have failed or when the infection is particularly severe.

  • Complicated Urinary Tract Infections (cUTI): Including acute pyelonephritis (kidney infection).

  • Skin and Soft Tissue Infections: Indicated for complicated infections where deep tissue penetration is required.

  • Chronic Bacterial Prostatitis: Levofloxacin is preferred here due to its excellent penetration into prostatic fluid.

Mechanism of Action: DNA Fragmentation

Levofloxacin is a bactericidal agent that disrupts the vital machinery of the bacterial cell.

Enzyme Inhibition: It targets two essential enzymes: DNA gyrase (Topoisomerase II) and Topoisomerase IV.

Supercoiling Disruption: These enzymes are responsible for uncoiling and re-sealing bacterial DNA during replication. By blocking them, Levofloxacin causes the DNA strands to break.

Cell Death: The bacteria can no longer replicate its genetic material or synthesize proteins, leading to rapid cell death.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levofloxacin 750 mg is a technically demanding product:

  • Pharmacokinetics (): The 750 mg dose is specifically formulated to be “concentration-dependent.” As a firm owner, you should know that achieving bioequivalence against the innovator (Levaquin) requires precise control over the dissolution rate to ensure rapid absorption.

  • Photosensitivity: Levofloxacin is sensitive to light. At our WHO-GMP facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Dossier & Regulatory Support: This is a high-value antibiotic for hospital supply. We provide full CTD/eCTD Dossiers to support international registration and B2B tender participation.

  • Safety Monitoring: As a pharmacist, you must ensure your labeling includes the FDA “Black Box Warning” regarding tendonitis and tendon rupture, which is a critical regulatory requirement for fluoroquinolones.

 

What is Levamisole 40 mg used for?

In the pharmaceutical industry, Levamisole 40 mg is a unique molecule that serves a dual purpose as both an anthelmintic (anti-parasitic) and an immunomodulator. As a pharmacist and manufacturer, I view Levamisole as a versatile “old-school” drug that has found modern applications in specialized medicine, although its use as a dewormer has largely been superseded by newer agents like Albendazole in many regions.

Primary Clinical Uses

  • Ascariasis (Roundworm): It is highly effective in treating infections caused by Ascaris lumbricoides. A single dose is often sufficient to paralyze the worms, which are then expelled naturally from the body.

  • Adjuvant Cancer Therapy: Historically used in combination with Fluorouracil (5-FU) to treat Stage III colon cancer after surgical resection.

  • Nephrotic Syndrome: Used in pediatric medicine (often off-label) for steroid-dependent nephrotic syndrome to help maintain remission and reduce the need for high-dose steroids.

  • Immunomodulation: It can “reset” a depressed immune system by stimulating T-cell function and macrophage activity, making it useful in certain chronic infections or autoimmune conditions.

Mechanism of Action: Paralyzing and Stimulating

Levamisole works differently depending on the target:

Anthelmintic Action: It acts as a nicotinic acetylcholine receptor agonist in the muscle of the parasite. This causes a continuous muscle contraction, leading to spastic paralysis of the worm. Once paralyzed, the worm loses its grip on the intestinal wall and is eliminated via peristalsis.

Immunomodulatory Action: It restores immune function by increasing the chemotaxis and phagocytosis of neutrophils and stimulating the proliferation of T-lymphocytes.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Levamisole 40 mg requires careful regulatory and technical handling:

  • Veterinary vs. Human Grade: As a manufacturer, we must strictly distinguish between human-grade and veterinary-grade (Levamisole is very common in livestock). Our WHO-GMP facility ensures the highest purity and adherence to BP/USP/IP monographs for human consumption.

  • Side Effect Monitoring (Agranulocytosis): One of the primary reasons Levamisole use is restricted in some Western markets is the risk of agranulocytosis (a severe drop in white blood cells). In your eCTD Dossier and Product Information Leaflets (PIL), detailed blood monitoring instructions are essential for regulatory compliance.

  • Stability for Global Trade: Levamisole Hydrochloride is relatively stable but must be protected from light. We utilize Alu-Alu or Amber-colored PVC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Public Health Tenders: This remains a high-volume product for deworming programs in specific developing markets. Our Mumbai facility provides the stability data and dossiers required for these government tenders.

What is leflunomide 20 mg used for?

In the pharmaceutical industry, Leflunomide 20 mg is a potent Disease-Modifying Antirheumatic Drug (DMARD). As a pharmacist, I classify this as an “immunomodulatory” agent. Unlike NSAIDs which only mask pain, Leflunomide is designed to slow down the underlying disease progression and prevent structural joint damage.

Primary Clinical Uses

  • Active Rheumatoid Arthritis (RA): The primary indication for reducing signs and symptoms and inhibiting structural damage (joint erosion and joint space narrowing).

  • Psoriatic Arthritis (PsA): Used to treat the joint inflammation associated with psoriasis, improving physical function and reducing skin involvement.

  • Lupus Nephritis (Off-label): Occasionally used in specialized rheumatology for refractory cases of SLE where other treatments have failed.

Mechanism of Action: Inhibiting Pyrimidine Synthesis

Leflunomide is a prodrug that is rapidly converted in the intestinal wall and liver to its active metabolite, teriflunomide.

Enzyme Inhibition: It inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH).

Pyrimidine Depletion: This enzyme is essential for the de novo synthesis of uridine monophosphate (rUMP), a building block for DNA and RNA.

Lymphocyte Suppression: Rapidly dividing cells, like activated T-lymphocytes (which cause the inflammation in RA), depend on this de novo pathway. By cutting off their supply of pyrimidines, Leflunomide effectively “starves” the overactive immune cells, reducing joint inflammation without suppressing the rest of the immune system as severely as some other drugs.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Leflunomide requires specific professional handling:

  • The Loading Dose vs. Maintenance: Historically, a 100 mg “loading dose” was used for three days, but most modern protocols start directly with the 20 mg maintenance dose to reduce GI side effects. In your Product Information Leaflet (PIL), it is vital to reflect current clinical guidelines for your B2B buyers.

  • Teratogenicity & “Washout” Procedures: Leflunomide has a very long half-life (up to 2 weeks) and is highly teratogenic. As a manufacturer, we must include strict warnings and the Cholestyramine washout protocol in our documentation to ensure safety for patients of childbearing age.

  • Stability for Export: Leflunomide is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging at our WHO-GMP facility to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This is a high-value item in the rheumatology segment. Our Mumbai facility provides full CTD/eCTD Dossiers to support registration against the innovator (Arava).

What is lamivudine and zidovudine tablets used for?

In the pharmaceutical industry, the fixed-dose combination (FDC) of Lamivudine (150 mg) and Zidovudine (300 mg) is a foundational dual-NRTI (Nucleoside Reverse Transcriptase Inhibitor) backbone for HIV therapy. As a pharmacist and manufacturer, I view this combination as a critical component of Highly Active Antiretroviral Therapy (HAART), designed to simplify dosing and reduce the “pill burden” for patients.

Primary Clinical Uses

  • HIV-1 Infection: Used in combination with at least one other antiretroviral (such as a Protease Inhibitor or an NNRTI) to manage HIV. It is not a cure but effectively slows the progression of the disease.

  • Post-Exposure Prophylaxis (PEP): It is a standard regimen for healthcare workers or individuals who have had a potential occupational or non-occupational exposure to HIV, usually taken for 28 days.

  • Prevention of Mother-to-Child Transmission (PMTCT): Used during pregnancy and labor to reduce the risk of transmitting HIV to the fetus.

Mechanism of Action: Dual Chain Termination

Both drugs are pro-drugs that must be phosphorylated within the cell to their active triphosphate forms.

Competitive Inhibition: They compete with natural deoxynucleosides for a spot in the viral DNA chain being built by the enzyme Reverse Transcriptase.

The “Fake” Building Block: Because these molecules lack a 3′-hydroxyl group, once they are incorporated into the viral DNA string, no further building blocks can be added.

Viral Suppression: This leads to DNA chain termination, preventing the virus from converting its RNA into DNA and stopping it from integrating into the human host cell’s genome.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint in a WHO-GMP facility, this FDC requires specific attention to stability and bioequivalence:

  • Bioequivalence (BE) Challenges: As a firm owner, you know that achieving BE against the innovator (Combivir) is essential for export. We conduct rigorous dissolution testing in multiple pH media to ensure the release profiles of both APIs meet international standards.

  • Zidovudine Stability: Zidovudine is sensitive to light. At our Mumbai facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to prevent degradation and ensure a 36-month shelf life.

  • Market Position: While many markets have moved toward Tenofovir-based backbones, the Lamivudine + Zidovudine combination remains vital for patients who cannot tolerate Tenofovir (e.g., those with renal issues).

  • B2B & Dossiers: We provide the full eCTD Dossier and stability data required for registration in Zone IVb markets (Africa, SE Asia), making this a high-volume product for institutional tenders.

Add to cart